All In MedTech

FDA Clearance Tracker · P150002

INCRAFT(R) AAA STENT GRAFT SYSTEM

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Nov 27, 2018 (this decision)Source: openFDAMethods & limitations

PMA

Decided

Nov 27, 2018

Approval withdrawn

Time to decision

1,412 days

Received Jan 15, 2015. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P150002
Device name
INCRAFT(R) AAA STENT GRAFT SYSTEM
Applicant location
Miami Lakes, FL
Received
Jan 15, 2015
Decided
Nov 27, 2018
Decision
Approval withdrawn
Supplements
11 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code MIH

FDA's approval statement

As written in FDA's record.

Approval for the endovascular treatment of patients with infrarenal abdominal aortic aneurysms with the following characteristics:1) Adequate, but complex iliac or femoral vessel morphology (e.g., high tortuosity index, heavily calcified, small diameter), that is compatible with vascular access techniques, devices or accessories;2) Proximal neck length >= 10 mm;3) Aortic neck diameters >=17 mm and <= 31 mm;4) Aortic neck suitable for suprarenal fixation;5) Infrarenal and suprarenal neck angulation <= 60°;6) Iliac fixation length >= 15 mm;7) Iliac diameters >= 7 mm and <= 22 mm; and 8) Minimum overall AAA treatment length (proximal landing location to distal landing location) >= 128 mm.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code MIH. The earliest in FDA's data is P990017, decided Sep 28, 1999.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Cordis US Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.